LW
BIIB icon

Linscomb Wealth’s Biogen BIIB Stock Holding History

Linscomb Wealth’s Portfolio BIIB Stock Details BIIB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q2 		– Sell
-1,851
Closed -$438K – 268
2019
Q1 		$438K Buy
1,851
+224
+14% +$70.5K 0.04% 193
2018
Q4 		$490K Sell
1,627
-181
-10% -$57.8K 0.05% 167
2018
Q3 		$639K Buy
1,808
+102
+6% +$35.1K 0.05% 157
2018
Q2 		$495K Buy
1,706
+241
+16% +$67.8K 0.04% 173
2018
Q1 		$401K Sell
1,465
-16
-1% -$4.97K 0.03% 190
2017
Q4 		$472K Buy
1,481
+176
+13% +$56.5K 0.04% 183
2017
Q3 		$409K Buy
1,305
+101
+8% +$29.9K 0.04% 193
2017
Q2 		$327K Buy
1,204
+29
+2% +$7.67K 0.03% 197
2017
Q1 		$321K Buy
1,175
+47
+4% +$13.3K 0.03% 195
2016
Q4 		$320K Buy
1,128
+169
+18% +$50.1K 0.03% 203
2016
Q3 		$300K Buy
959
+1
+0.1% +$296 0.03% 203
2016
Q2 		$232K Buy
958
+54
+6% +$14.2K 0.02% 227
2016
Q1 		$235K Buy
+904
New +$239K 0.03% 226

Other funds holding BIIB

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Linscomb Wealth's BIIB Position: Q2 2019 in Review

Linscomb Wealth sold out of Biogen (BIIB) in Q2 2019, closing a stake of 1,851 shares — an estimated $438K sold.

Linscomb Wealth first reported a position in BIIB in Q1 2016 and held it in 13 quarters. The position peaked at $639K in Q3 2018. 1,010 funds tracked by Wall St. Rank hold BIIB as of Q2 2019.

  • Linscomb Wealth reported no remaining Biogen position as of Q2 2019 after selling out during the quarter.
  • Linscomb Wealth sold 1,851 Biogen shares in Q2 2019, an estimated $438K.
  • Linscomb Wealth first reported a position in Biogen in Q1 2016 and held it in 13 quarters.
  • Linscomb Wealth's Biogen position peaked at $639K in Q3 2018.
  • 1,010 funds tracked by Wall St. Rank held Biogen as of Q2 2019.

Based on Linscomb Wealth's 13F filing for Q2 2019, filed 6 Aug 2019.